Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
NCT07291635
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
728
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Recombinant Influenza vaccine candidate
BIOLOGICAL:
Commercial Influenza vaccine
Sponsor
Aramis Biotechnologies Inc.